U · A
Unknown Author
February 23, 2026
Gibson Dunn Advised Galecto on Public Offering of Common Stock
1 min
AI-made summary
- • Gibson Dunn advised Galecto, Inc
- on a public offering of common stock
- • The offering generated approximately $316 million in aggregate gross proceeds for Galecto
- • Galecto is a biopharmaceutical company focused on developing therapeutics for blood cancers
- • The Gibson Dunn team included partners Ryan Murr, Branden Berns, Melanie Neary, and several associates.
Gibson Dunn advised Galecto, Inc. on its public offering of common stock, which generated aggregate gross proceeds to the company of approximately $316 million.~~Galecto is a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers.~~The Gibson Dunn corporate team included partners Ryan Murr, Branden Berns, and Melanie Neary and associates Nicholas Linke, Candice Johnson, Lauren Navarro, and Chad Kang.~~Download PDF~~
U
Article Author
Unknown Author
The Sponsor